{"log_id": 1587507905693737269, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0.000664, "average": 0.972457, "min": 0.946681}, "location": {"width": 41, "top": 161, "height": 23, "left": 291}, "words": "头痛"}, {"probability": {"variance": 0, "average": 0.999778, "min": 0.999192}, "location": {"width": 86, "top": 191, "height": 25, "left": 288}, "words": "感觉异常"}, {"probability": {"variance": 0.000136, "average": 0.986919, "min": 0.975264}, "location": {"width": 46, "top": 222, "height": 24, "left": 286}, "words": "胸痛"}, {"probability": {"variance": 1.6e-05, "average": 0.995973, "min": 0.98915}, "location": {"width": 84, "top": 255, "height": 22, "left": 288}, "words": "尿路感染"}, {"probability": {"variance": 0.02757, "average": 0.833946, "min": 0.667906}, "location": {"width": 44, "top": 285, "height": 23, "left": 285}, "words": "牙病"}, {"probability": {"variance": 0, "average": 0.999955, "min": 0.999913}, "location": {"width": 44, "top": 316, "height": 25, "left": 284}, "words": "过敏"}, {"probability": {"variance": 0.022052, "average": 0.939089, "min": 0.412214}, "location": {"width": 505, "top": 359, "height": 25, "left": 359}, "words": "空白对照研究中瑞格列奈的发生率2%空白对照组"}, {"probability": {"variance": 0.002677, "average": 0.975443, "min": 0.849411}, "location": {"width": 144, "top": 403, "height": 24, "left": 128}, "words": "心血管不良反应"}, {"probability": {"variance": 0.000659, "average": 0.987701, "min": 0.865006}, "location": {"width": 743, "top": 449, "height": 32, "left": 170}, "words": "在为期一年的瑞格列奈和磺酰脲类药物的对照试验中,两者心绞痛的发生率相当("}, {"probability": {"variance": 0.030038, "average": 0.841833, "min": 0.585638}, "location": {"width": 100, "top": 457, "height": 24, "left": 984}, "words": "胸痛的发生"}, {"probability": {"variance": 0.01538, "average": 0.940176, "min": 0.510977}, "location": {"width": 957, "top": 494, "height": 33, "left": 125}, "words": "率,瑞格列奈组为1.8%,磺酰脲组为1.0%。选择性心血管不良反应(高血压、心电图异常、心肌梗死、心"}, {"probability": {"variance": 0.007543, "average": 0.966974, "min": 0.609744}, "location": {"width": 656, "top": 541, "height": 30, "left": 125}, "words": "律不齐利心悸)的发生率,瑞格列奈组和对照药物组没有差异,均≤1.0%"}, {"probability": {"variance": 0.002541, "average": 0.984588, "min": 0.717599}, "location": {"width": 847, "top": 588, "height": 33, "left": 166}, "words": "在对照比较的临床试验中,包括缺血在内的严重心血管不良反应的总发生率方面,端格列奈组"}, {"probability": {"variance": 0.005534, "average": 0.970398, "min": 0.500626}, "location": {"width": 957, "top": 633, "height": 35, "left": 123}, "words": "要高于磺酰脲(3%)。在一项为期1年的对照试验中,与其他口服降糖药观察到的儿率相比,瑞格列奈治"}, {"probability": {"variance": 0.016912, "average": 0.923726, "min": 0.590407}, "location": {"width": 185, "top": 682, "height": 23, "left": 122}, "words": "没有较高的死亡率"}, {"probability": {"variance": 0.002216, "average": 0.972625, "min": 0.862142}, "location": {"width": 336, "top": 730, "height": 26, "left": 434}, "words": "表2瑞格列奈和磺酰尿类对照试验中"}, {"probability": {"variance": 7.1e-05, "average": 0.99613, "min": 0.95901}, "location": {"width": 649, "top": 775, "height": 32, "left": 277}, "words": "严重心血管不良反应发生几率(占发生不良反应患者总数的比例)概况"}, {"probability": {"variance": 0.039492, "average": 0.874805, "min": 0.530736}, "location": {"width": 85, "top": 829, "height": 24, "left": 471}, "words": "瑞格列奈"}, {"probability": {"variance": 0.001285, "average": 0.973637, "min": 0.911815}, "location": {"width": 89, "top": 830, "height": 24, "left": 749}, "words": "磺酰尿类"}, {"probability": {"variance": 0.00188, "average": 0.979229, "min": 0.882303}, "location": {"width": 124, "top": 874, "height": 25, "left": 189}, "words": "总受试者人数"}, {"probability": {"variance": 0.01552, "average": 0.898253, "min": 0.722437}, "location": {"width": 40, "top": 871, "height": 31, "left": 472}, "words": "128"}, {"probability": {"variance": 6e-05, "average": 0.996575, "min": 0.977638}, "location": {"width": 161, "top": 920, "height": 24, "left": 215}, "words": "心血管不良反应"}, {"probability": {"variance": 2.3e-05, "average": 0.9937, "min": 0.988878}, "location": {"width": 37, "top": 923, "height": 29, "left": 467}, "words": "4%"}, {"probability": {"variance": 0.027041, "average": 0.873968, "min": 0.641415}, "location": {"width": 25, "top": 879, "height": 116, "left": 751}, "words": "9%%"}, {"probability": {"variance": 0, "average": 0.999513, "min": 0.998806}, "location": {"width": 82, "top": 968, "height": 24, "left": 187}, "words": "心脏缺血"}, {"probability": {"variance": 2e-06, "average": 0.998076, "min": 0.996653}, "location": {"width": 38, "top": 963, "height": 35, "left": 462}, "words": "2%"}, {"probability": {"variance": 0.035994, "average": 0.840233, "min": 0.485613}, "location": {"width": 146, "top": 1015, "height": 25, "left": 187}, "words": "死于心血管事件"}, {"probability": {"variance": 5e-06, "average": 0.998055, "min": 0.99412}, "location": {"width": 47, "top": 1020, "height": 20, "left": 466}, "words": "0.5%"}, {"probability": {"variance": 3.3e-05, "average": 0.993967, "min": 0.985708}, "location": {"width": 47, "top": 1022, "height": 19, "left": 743}, "words": "0.4%"}, {"probability": {"variance": 0.000179, "average": 0.985391, "min": 0.953379}, "location": {"width": 191, "top": 1067, "height": 24, "left": 258}, "words": "格列本脲和格列吡嗪"}, {"probability": {"variance": 0.004242, "average": 0.972228, "min": 0.667914}, "location": {"width": 931, "top": 1112, "height": 33, "left": 143}, "words": "7项对照临床试验中,包括瑞格列奈和低精蛋白锌胰岛素合用(n=431),单用胰岛泰制剂(n=388)以及"}, {"probability": {"variance": 0.003367, "average": 0.97516, "min": 0.665284}, "location": {"width": 727, "top": 1159, "height": 28, "left": 113}, "words": "其他合用方案(磺酰脲+低精蛋白锌胰岛素,或者瑞格列奈十二甲双胍)(n=120)。"}, {"probability": {"variance": 0.00547, "average": 0.980593, "min": 0.525542}, "location": {"width": 917, "top": 1205, "height": 33, "left": 154}, "words": "在两项研究中,瑞格列奈+低精蛋白锌胰岛素治疗的患者中共有6例出现了心肌缺血这一严重的不良反"}, {"probability": {"variance": 0.00215, "average": 0.988956, "min": 0.732598}, "location": {"width": 662, "top": 1254, "height": 27, "left": 113}, "words": "应,在另一项研究中,单用胰岛素制剂的患者中则有1例出现该不良反应"}, {"probability": {"variance": 0.000587, "average": 0.988175, "min": 0.934056}, "location": {"width": 124, "top": 1303, "height": 25, "left": 111}, "words": "其他不良反应"}, {"probability": {"variance": 0.014828, "average": 0.960923, "min": 0.459686}, "location": {"width": 909, "top": 1348, "height": 32, "left": 152}, "words": "临床试验中观察到的少见临床和实验室不良反应包括过敏反应、肝酶升高、血小板减少和白细胞减少"}, {"probability": {"variance": 0.007356, "average": 0.971434, "min": 0.52971}, "location": {"width": 955, "top": 1373, "height": 56, "left": 109}, "words": "非常罕见的不良反应有眼睛异常(已知糖水平的改变可导致舞时性的视觉异常,尤其是在开始使"}, {"probability": {"variance": 0.005785, "average": 0.981382, "min": 0.583466}, "location": {"width": 603, "top": 1444, "height": 27, "left": 108}, "words": "药物进行治疗时,这些改变通常是一过性的)或免疫反应如脉管炎"}, {"probability": {"variance": 0.007842, "average": 0.978952, "min": 0.414594}, "location": {"width": 888, "top": 1491, "height": 29, "left": 149}, "words": "虽然尚确定与瑞格列奈之间的因果关系,但是上市后报道的罕见不良反应如下:脱发、溶血性贫"}], "language": 3}